Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Therapeutic advances for glioblastoma have been minimal over the past 2 decades. In light of the multitude of recent phase III trials that have failed to meet their primary endpoints following promising preclinical and early-phase programs, a Society for Neuro-Oncology Think Tank was held in Novembe...

Full description

Bibliographic Details
Main Authors: Ahluwalia, M.S (Author), Bagley, S.J (Author), Chang, S.M (Author), Cloughesy, T.F (Author), Dunn, G.P (Author), Galanis, E. (Author), Grossman, S.A (Author), Khagi, S. (Author), Khasraw, M. (Author), Kothari, S. (Author), Lee, E.Q (Author), Mehta, M.P (Author), Nabors, L.B (Author), Rahman, R. (Author), Reardon, D.A (Author), Sampson, J.H (Author), Stupp, R. (Author), Sulman, E.P (Author), Weller, M. (Author), Wen, P.Y (Author)
Format: Article
Language:English
Published: American Association for Cancer Research Inc. 2022
Online Access:View Fulltext in Publisher